Integral Molecular and Optimeos Partner to Deliver Long-acting Therapeutic Antibodies Using Nanoparticle Formulation Technology
1/7/21

Integral Molecular Announces Best-in-Class Antibodies Against Complex Oncology Target Claudin
11/24/20